First-Ever Patient-Initiated "Guidance for Industry" for Duchenne Muscular Dystrophy Submitted to FDA

Parent Project Muscular Dystrophy-led guidance seeks to address unmet clinical needs of individuals with Duchenne muscular dystrophy and accelerate development of safe and effective therapies

Jun 25, 2014, 11:00 ET from Parent Project Muscular Dystrophy